Literature DB >> 33316951

High Capability of Pentagalloylglucose (PGG) in Inhibiting Multiple Types of Membrane Ionic Currents.

Wei-Ting Chang1,2,3, Ping-Yen Liu1,4, Sheng-Nan Wu5,6,7.   

Abstract

Pentagalloyglucose (PGG, penta-O-galloyl-β-d-glucose; 1,2,3,4,6-pentagalloyl glucose), a pentagallic acid ester of glucose, is recognized to possess anti-bacterial, anti-oxidative and anti-neoplastic activities. However, to what extent PGG or other polyphenolic compounds can perturb the magnitude and/or gating of different types of plasmalemmal ionic currents remains largely uncertain. In pituitary tumor (GH3) cells, we found out that PGG was effective at suppressing the density of delayed-rectifier K+ current (IK(DR)) concentration-dependently. The addition of PGG could suppress the density of proton-activated Cl- current (IPAC) observed in GH3 cells. The IC50 value required for the inhibitory action of PGG on IK(DR) or IPAC observed in GH3 cells was estimated to be 3.6 or 12.2 μM, respectively, while PGG (10 μM) mildly inhibited the density of the erg-mediated K+ current or voltage-gated Na+ current. The presence of neither chlorotoxin, hesperetin, kaempferol, morin nor iberiotoxin had any effects on IPAC density, whereas hydroxychloroquine or 4-[(2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5yl)oxy] butanoic acid suppressed current density effectively. The application of PGG also led to a decrease in the area of voltage-dependent hysteresis of IPAC elicited by long-lasting isosceles-triangular ramp voltage command, suggesting that hysteretic strength was lessened in its presence. In human cardiac myocytes, the exposure to PGG also resulted in a reduction of ramp-induced IK(DR) density. Taken literally, PGG-perturbed adjustment of ionic currents could be direct and appears to be independent of its anti-oxidative property.

Entities:  

Keywords:  erg-mediated K+ current; heart cell; hyperpolarization-activated cation current; pentagalloylglucose (penta-O-galloyl-β-d-glucose), delayed-rectifier K+ current; pituitary cell; proton-activated Cl− current; voltage-gated Na+ current

Mesh:

Substances:

Year:  2020        PMID: 33316951      PMCID: PMC7763472          DOI: 10.3390/ijms21249369

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  50 in total

Review 1.  Hydroxychloroquine in systemic lupus erythematosus (SLE).

Authors:  C Ponticelli; G Moroni
Journal:  Expert Opin Drug Saf       Date:  2016-12-14       Impact factor: 4.250

Review 2.  Intracellular Ca2+ and Cl- channel activation in secretory cells.

Authors:  J F Kidd; P Thorn
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

3.  A pH-independent DNA nanodevice for quantifying chloride transport in organelles of living cells.

Authors:  Sonali Saha; Ved Prakash; Saheli Halder; Kasturi Chakraborty; Yamuna Krishnan
Journal:  Nat Nanotechnol       Date:  2015-06-22       Impact factor: 39.213

4.  Role of K(+) channels in frequency regulation of spontaneous action potentials in rat pituitary GH(3) cells.

Authors:  Suk-Ho Lee; Eun Hae Lee; Shin Young Ryu; Hyewhon Rhim; Hye-Jung Baek; Wonil Lim; Won-Kyung Ho
Journal:  Neuroendocrinology       Date:  2003-11       Impact factor: 4.914

5.  Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins.

Authors:  Wei-Jen Chen; Jen-Kun Lin
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

Review 6.  Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose.

Authors:  Jinhui Zhang; Li Li; Sung-Hoon Kim; Ann E Hagerman; Junxuan Lü
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

7.  Inhibition of human immunodeficiency viral replication by tannins and related compounds.

Authors:  H Nakashima; T Murakami; N Yamamoto; H Sakagami; S Tanuma; T Hatano; T Yoshida; T Okuda
Journal:  Antiviral Res       Date:  1992-05       Impact factor: 5.970

8.  Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor.

Authors:  Te-Ling Lu; Wei-Ting Chang; Chee-Hong Chan; Sheng-Nan Wu
Journal:  Front Pharmacol       Date:  2019-02-18       Impact factor: 5.810

9.  PAC proton-activated chloride channel contributes to acid-induced cell death in primary rat cortical neurons.

Authors:  James Osei-Owusu; Junhua Yang; Maria Del Carmen Vitery; Mengnan Tian; Zhaozhu Qiu
Journal:  Channels (Austin)       Date:  2020-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.